FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel ... (LinkName('Company Sanpshot')); BMY ) as...)

FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)

Date:9/27/2007

LinkName('Company Sanpshot'));" >BMY) as Plavix(R) and Iscover(R).

If you have a stomach ulcer or other condition that causes bleeding, you should not use Plavix. When taking Plavix alone or with some other medicines including aspirin, the risk of bleeding may increase so tell your doctor before planning surgery. And, always talk to your doctor before taking aspirin or other medicines with Plavix, especially if you've had a stroke. If you develop fever, unexplained weakness or confusion, tell your doctor promptly as these may be signs of a rare but potentially life-threatening condition called TTP, which has been reported rarely, sometimes in less than 2 weeks after starting therapy. Other rare but serious side effects may occur.

For more information on PLAVIX visit http://www.plavix.com.

WHO SHOULD RECEIVE Plavix (clopidogrel bisulfate)?

PLAVIX is indicated for the reduction of atherothrombotic events as follows:

-- Recent Myocardial Infarction (MI), Recent Stroke, or Established

Peripheral Arterial Disease (PAD)

For patients with a history of recent MI, recent stroke, or established

PAD, PLAVIX has been shown to reduce the rate of a combined end point

of new ischemic stroke (fatal or not), new MI (fatal or not), and other

vascular death.

-- Acute Coronary Syndrome (ACS)

For patients with non-ST-segment elevation ACS (unstable angina/non-Q-

wave MI), including patients who are to be managed medically and those

who are to be managed with percutaneous coronary intervention (with or

without stent) or coronary artery bypass graft surgery (CABG), PLAVIX

has been shown to decrease the rate of a combined end point of

cardiovascular death, MI, or stroke as well as the rate of a combined

end point of cardiovascular death, MI, stroke, or refractory ischemia.

For patients w
'/>"/>

0

GOOD

Page: 1 2 3 4 5
Related biology technology :

1. UW-Madison approves new research institute
2. FDA approves GEs heart-imaging technology
3. Senate approves bill to expand stem cell funding
4. FDA approves advanced digital mammography system
5. Building commission approves Institutes for Discovery
6. UW Board of Regents approves $134 million medical research facility
7. FDA approves Bone Cares Hectorol for treatment of kidney disease
8. Integration of the LEADseeker Multimodality Imaging System with automated plate loading and incubation using Overlord Instrument software
9. Marquette targets illegal downloading
10. Though VC investing is down, reloading on new funds is rising

Post Your Comments:

FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel ...(LinkName('Company Sanpshot')); BMY ) as...)